Expected in the first half of 2028, the planned separation would create a stand-alone retail pharmacy company with nearly 30,000 pharmacists.
|Articles|January 16, 2016
Government-Backed Cancer Fighting Initiative Tops Week in Health Care News
Author(s)Davy James, Managing Editor
Catch up with the latest developments across the health care landscape and sign up for key upcoming conferences.
Advertisement
[<a href="//storify.com/pharmacytimes/government-backed-cancer-fighting-initiative" target="_blank">View the story "Government-Backed Cancer Fighting Initiative Tops Week in Health Care News" on Storify</a>]
Advertisement
Related to this article
Doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd (Voceryq) targets HPV-6 and HPV-11 to reduce the surgical burden for adults with recurrent respiratory papillomatosis, a rare airway disease.
Cody Parsons, APh, PharmD, BCCCP, says protected pharmacist access lets patients with heart failure be seen more often than typical clinic visits allow.
The evidence for GLP-1 receptor agonists keeps growing, while access for low-income patients keeps narrowing.
Specialty pharmacists can help patients with cancer weigh the benefits and risks of GLP-1 receptor agonists as use expands and new evidence emerges.
If gene therapies are expected to deliver decades of benefit, long-term evidence collection must be coordinated, useful to patients, and financially sustainable.
As kratom questions increase, many pharmacists and other health care professionals may remain unfamiliar it and the potential risks.
Pharmacists can work alongside dermatologists, nurses, and other health care professionals to help answer skin care–related questions and help patients understand trial outcomes.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Understanding Kratom: Pharmacology, Safety, and Regulation
2
GLP-1s and Obesity Care: Cardiorenal Outcomes, Prescribing Considerations, and Access Barriers
3
GLP-1 Receptor Agonists and Cancer: Considerations for Specialty Pharmacists
4
How Stanford Pharmacists Help Close Heart Failure Therapy Gaps
5